Global Heart Pump Device Market Size, Trends & Growth Opportunity, By Product (Ventricular Assist Devices (VADs), Intra-Aortic Balloon Pumps (IABPs), and Total Artificial Heart (TAH)), By Type (Implantable Heart Pump Devices, and Extracorporeal Heart Pump Devices), By Therapy (Bridge-To-Transplant (BTT), Bridge-To-Candidancy (BTC), Destination Therapy (DT), and Other Therapies), By Region and Forecast 2022-2027.
Report ID : IR100291 | Industries : Energy & Power | Published On :May 2024 | Page Count : 241
Global Heart Pump Device Market Size, Trends & Growth Opportunity, By Product (Ventricular Assist Devices (VADs), Intra-Aortic Balloon Pumps (IABPs), and Total Artificial Heart (TAH)), By Type (Implantable Heart Pump Devices, and Extracorporeal Heart Pump Devices), By Therapy (Bridge-To-Transplant (BTT), Bridge-To-Candidancy (BTC), Destination Therapy (DT), and Other Therapies), By Region and Forecast 2022-2027.
Global Heart Pump Device Market
Global Heart Pump Device Market was valued at USD 3.2 billion in 2021 which expected to reach at USD 10.2 billion by 2027, at a CAGR 14.19%
Heart failure is characterised as a state in which the heart cannot pump enough blood to meet the needs of the body. Pre-myocardial infarction, excessive blood pressure, atrial fibrillation, cardiac disease, and other conditions can all contribute to this illness.
The mechanical equipment used to support heart function and blood flow in persons with weak hearts is referred to as a heart pump device. These devices let persons with uneven blood flow or weak heart muscles work normally for short or long periods of time.
Market Drivers
Over the course of the forecast period, the global market for heart pump devices is anticipated to grow as a result of the rise in the prevalence of cardiovascular illnesses. For instance, according to the Lancet study Global Burden of Disease, around 26 million people worldwide suffered from heart failure in 2017. Additionally, the growing elderly population will have a beneficial impact on the expansion of the global market for heart pump devices during this projection period.
Furthermore, new product launches by key competitors projected to boost the global heart pump device market expansion. Moreover, the increase in new product approvals by regulatory bodies would help the growth of worldwide heart pump device market. For instance, Abbott's surgical approach using the HeartMate 3 heart pump was approved by the USFDA (Food and Drug Administration) in January 2020. In order to prevent open heart surgery, these devices are utilized to treat individuals with heart failure. In the past, open heart surgery has been used to implant heart pumps. Now that a different surgical approach has been approved, the HeartMate 3 heart pump can be placed by lateral thoracotomy. (is a surgical technique where a patient's ribs are cut to provide access to the heart).
Market Restraints
The primary restraint that is anticipated to impede the expansion of the global market for heart pump devices is product recall. For instance, due to patient fatalities, Medtronic removed its HeartWare HVAD pump system from the market in March 2021. Additionally, during the course of the projection period, a shortage of qualified specialists and high costs could impede the expansion of the global market for heart pump devices.
Market Segmentation
The Global Heart Pump Device Market is segmented into product such as Ventricular Assist Devices (VADs), Intra-Aortic Balloon Pumps (IABPs), and Total Artificial Heart (TAH). The Ventricular Assist Devices (VADs) are expected to hold largest share of the heart pump device market over the forecast period. Further, market is segmented into type such as Implantable Heart Pump Devices, and Extracorporeal Heart Pump Devices. The implantable heart pump devices registered for the largest market share of the market, owing to the introduction of innovative products by leading players and the rise in need for an efficient solution to manage heart failure.
Also, the Global Heart Pump Device Market is segmented into therapy such as Bridge-To-Transplant (BTT), Bridge-To-Candidancy (BTC), Destination Therapy (DT), and Other Therapies.
Regional Analysis
The Global Heart Pump Device Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The heart pump device market is anticipated to generate the most revenue in Europe. Since more people are using heart pump devices, CVDs are becoming more common, and more research is being done to advance current technologies. Additionally, the Asia Pacific area is anticipated to offer tremendous prospects for market expansion in the near term due to the region's rising CVD mortality rate. For instance, the World Health Organization reports that more than 75% of deaths take place in middle-low income countries in 2016 (WHO factsheet).
Key players
Key players operating in the Global Heart Pump Device Market include, Abbott Laboratories, Teleflex Incorporated, Medtronic, Abiomed, SynCardia Systems, Fresenius Medical Care AG & Co. KGaA, CardiacAssist, Inc., Getinge, CARMAT, SENKO MEDICAL INSTRUMENT Mfg. CO., LTD, etc.
Market Taxonomy
By Product
• Ventricular Assist Devices (VADs)
• Intra-Aortic Balloon Pumps (IABPs)
• Total Artificial Heart (TAH)
By Type
• Implantable Heart Pump Devices
• Extracorporeal Heart Pump Devices
By Therapy
• Bridge-To-Transplant (BTT)
• Bridge-To-Candidancy (BTC)
• Destination Therapy (DT)
• Other Therapies
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Heart Pump Device Market TOC:
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Heart Pump Device Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Heart Pump Device Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Heart Pump Device Market Share Analysis, By Product
5.3 Global Heart Pump Device Market Size and Forecast, By Product
5.3.1 Ventricular Assist Devices (VADs)
5.3.2. Intra-Aortic Balloon Pumps (IABPs)
5.3.3. Total Artificial Heart (TAH)
6 Global Heart Pump Device Market, By Type
6.1 Y-o-Y Growth Comparison, By Type
6.2 Global Heart Pump Device Market Share Analysis, By Type
6.3 Global Heart Pump Device Market Size and Forecast, By Type
6.3.1 Implantable Heart Pump Devices
6.3.2 Extracorporeal Heart Pump Devices
7 Global Heart Pump Device Market, By Therapy
7.1 Y-o-Y Growth Comparison, By Therapy
7.2 Global Heart Pump Device Market Share Analysis, By Therapy
7.3 Global Heart Pump Device Market Size and Forecast, By Therapy
7.3. 1 Bridge-To-Transplant (BTT)
7.3.2. Bridge-To-Candidancy (BTC)
7.3.3. Destination Therapy (DT)
7.3.4. Other Therapies
8Global Heart Pump Device Market, By Region
8.1 Global Heart Pump Device Market Share Analysis, By Region
8.2 Global Heart Pump Device Market Share Analysis, By Region
8.3 Global Heart Pump Device Market Size and Forecast, By Region
9 North America Heart Pump Device Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Heart Pump Device Market Share Analysis, By Product
9.3 North America Heart Pump Device Market Size and Forecast, By Type
9.4 North America Heart Pump Device Market Size and Forecast, By Therapy
9.5 North America Heart Pump Device Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10EuropeHeart Pump Device Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Heart Pump Device Market Share Analysis, By Product
10.3 Europe Heart Pump Device Market Size and Forecast, By Type
10.4 Europe Heart Pump Device Market Size and Forecast, By Therapy
10.5 Europe Heart Pump Device Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Heart Pump Device Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Heart Pump Device Market Share Analysis, By Product
11.3 Asia Pacific Heart Pump Device Market Size and Forecast, By Type
11.4 Asia Pacific Heart Pump Device Market Size and Forecast, By Therapy
11.5 Asia Pacific Heart Pump Device Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Heart Pump Device Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Heart Pump Device Market Share Analysis, By Product
12.3 Latin America Heart Pump Device Market Size and Forecast, By Type
12.4 Latin America Heart Pump Device Market Size and Forecast, By Therapy
12.5 Latin America Heart Pump Device Market Size and Forecast, Country
13Middle East Heart Pump Device Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East Heart Pump Device Market Share Analysis, By Product
13.3 Middle East Heart Pump Device Market Size and Forecast, By Type
13.4 Middle East Heart Pump Device Market Size and Forecast, By Therapy
13.5 Middle East Heart Pump Device Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15. Company Profiles
15.1 Abbott Laboratories
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Teleflex Incorporated
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Medtronic
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Abiomed
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 SynCardia Systems
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Fresenius Medical Care AG & Co. KGaA
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 CardiacAssist, Inc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Getinge
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 CARMAT
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies